معرفی
Professor Ian Ford is a Senior Research Fellow at the Robertson Centre for Biostatistics, University of Glasgow. He specializes in cardiovascular medicine, biostatistics, and clinical trial design with a focus on heart failure, iron deficiency, and hemodialysis. His work includes leading the IRONMAN trial evaluating intravenous iron therapy in heart failure patients and contributing to major studies like the WAKE-UP trial for acute stroke treatment. He collaborates internationally on genomic research and cardiovascular outcomes analysis.
Research interests span heart failure management, genetic influences on cardiovascular diseases, and improving clinical trial methodologies. He has authored over 600 publications, emphasizing translational research between biostatistics and clinical practice.
Key contributions include advancing understanding of ferric derisomaltose efficacy, ivabradine's role in heart failure, and thrombolytic therapies in stroke. His work bridges statistical rigor with clinical applicability, addressing gaps in evidence-based treatments for chronic conditions.